1.04 (3.66%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Weak
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Strong
Website
Viking Therapeutics, Inc.
Telephone
1.858.704.4660
Address
Suite 350, 9920 Pacific Heights Boulevard, San Diego, CA 92121
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 22.96 - 43.15
Trade Value (12mth)
US$30,616,827.00
1 week
-6.18%
1 month
-15.98%
YTD
-19.82%
1 year
4.22%
All time high
99.41
EPS 3 yr Growth
256.10%
EBITDA Margin
0.00%
Operating Cashflow
-$279m
Free Cash Flow Return
-36.70%
ROIC
-47.30%
Interest Coverage
NaN
Quick Ratio
9.30
Shares Outstanding (Fully Diluted)
116m
HALO Sector
Healthcare
Next Company Report Date
10-Feb-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 30 April 26 | |
| 30 April 26 | |
| 30 April 26 | |
| 30 April 26 | |
| 30 April 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -0.91 | -1.01 | -3.19 | | | | ||
EPS (Fully Diluted) | $ | | | | | -0.91 | -1.01 | -3.19 | | | | ||
Growth | % | | | | | -1.6 | -10.8 | -216.5 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
